NC
LLY icon

NovaPoint Capital’s Eli Lilly LLY Stock Holding History

NovaPoint Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.27M Buy
6,061
+243
+4% +$248K 1.51% 23
2026
Q1 		$5.35M Buy
5,818
+311
+6% +$315K 1.34% 30
2025
Q4 		$5.92M Buy
5,507
+318
+6% +$304K 1.52% 24
2025
Q3 		$3.96M Buy
5,189
+1,860
+56% +$1.38M 0.97% 41
2025
Q2 		$2.6M Buy
3,329
+3,064
+1,156% +$2.38M 0.8% 51
2025
Q1 		$219K Hold
265
– – 0.07% 132
2024
Q4 		$205K Buy
+265
New +$219K 0.06% 127

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NovaPoint Capital's LLY Position: Q2 2026 in Review

NovaPoint Capital increased its Eli Lilly (LLY) stake by 4.2% in Q2 2026, buying an estimated $248K and bringing the position to 6,061 shares worth $7.27M. The position accounts for 1.51% of the portfolio, ranked #23.

NovaPoint Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • NovaPoint Capital held 6,061 shares of Eli Lilly worth $7.27M as of Q2 2026.
  • NovaPoint Capital bought 243 Eli Lilly shares in Q2 2026, an estimated $248K.
  • Eli Lilly made up 1.51% of NovaPoint Capital's portfolio in Q2 2026, its #23 holding.
  • NovaPoint Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.